MCIA Inc boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,786 shares of the healthcare conglomerate’s stock after purchasing an additional 50 shares during the period. UnitedHealth Group accounts for 1.0% of MCIA Inc’s investment portfolio, making the stock its 24th biggest holding. MCIA Inc’s holdings in UnitedHealth Group were worth $2,035,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Norges Bank purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $4,478,185,000. State Street Corp lifted its stake in shares of UnitedHealth Group by 1.9% in the 4th quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $22,877,432,000 after purchasing an additional 869,827 shares during the last quarter. Marshall Wace LLP raised its position in shares of UnitedHealth Group by 2,853.0% during the fourth quarter. Marshall Wace LLP now owns 861,798 shares of the healthcare conglomerate’s stock valued at $432,746,000 after buying an additional 832,614 shares during the last quarter. Capital International Investors raised its position in shares of UnitedHealth Group by 4.3% during the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $9,713,058,000 after buying an additional 790,219 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $346,859,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.
UNH opened at $489.68 on Thursday. The company’s 50 day simple moving average is $496.56 and its 200-day simple moving average is $490.86. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The stock has a market capitalization of $459.40 billion, a P/E ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a $1.65 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, June 16th. UnitedHealth Group’s dividend payout ratio is currently 36.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the sale, the director now directly owns 1,215,000 shares in the company, valued at $581,936,400. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Frederick William Mcnabb III bought 89 shares of the business’s stock in a transaction on Thursday, May 26th. The stock was purchased at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the completion of the acquisition, the director now owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The disclosure for this purchase can be found here. Corporate insiders own 0.40% of the company’s stock.
UNH has been the topic of a number of analyst reports. Morgan Stanley upped their target price on shares of UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research note on Monday, April 18th. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a research note on Monday, April 18th. Cowen upped their target price on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Barclays upped their target price on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research note on Wednesday, March 30th. Finally, Loop Capital began coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $555.73.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.